期刊文献+

CyclinD_1和p27^(kipl)在胰腺癌中的表达与意义

The significance and expression of CyclinD_1 and p27^(kipl) in pancreatic carcinoma
暂未订购
导出
摘要 目的 探讨CyclinD1和p2 7kipl在胰腺癌组织中的异常表达及其与临床和病理特征的关系。方法 应用免疫组化技术(SABC法 )检测 42例胰腺癌、2 0例正常胰腺及 15例急慢性胰腺炎组织CyclinD1和p2 7kipl的表达。结果 CyclinD1阳性表达率在胰腺癌组织中为 71 43 % ,显著高于正常胰腺 (0 )和胰腺炎组织 (40 % ) (P <0 0 5)。CyclinD1过表达与病人年龄、性别、肿瘤发生部位、组织分化程度、临床分期及淋巴结转移无关 (P >0 0 5)。p2 7kipl蛋白阳性表达在胰腺癌组织为 45 2 4% ,显著低于胰腺炎组织 (86 67% )(P <0 0 5) ,并与胰腺癌组织分化程度、临床分期及淋巴结转移相关 (P <0 0 5) ,与年龄、性别和肿瘤发生部位无关。两种蛋白之间无明显相关 (P >0 0 5)。结论 胰腺癌组织中CyclinD1过表达 ,p2 7kipl表达下降。CyclinD1和p2 7kipl与胰腺癌发生。 Objective To investigate the clinical significance of expression of CyclinD 1 and p27 kipl in pancreatic carcinoma. Methods Immunohistochemical technique(SABC) was applied to detect the expression of CyclinD 1 and p27 kipl in 42 specimen s of pancreatic carcinoma, 15 of pancreatitis and 20 of normal pancreatic tissue. ResultsThe Positive rate of CyclinD 1 protein in pancreatic carcinoma was 71 43%, much hig her than that in pancreatitis and normal pancreatic tissue (P<0.05),p27 kipl pro tein positive rate in pancreatic carcinoma was 45 24%, lower than that in pancreatitis (P <0 05), p27 kipl protein positive-expression was correlated signincantly with tumor cell differe tiation, clinical stage and lymph node metastasis (P<0 05). There was no significant correlat ion between the two proteins. Neither of them was correlated with the age, gender, tumor site. Conclusions The expression of CyclinD 1 in pancreatic carcinoma tissue is s ignincantly increased but the expression of p27 kipl is decreased.CyclinD 1 and p27 kipl might pla y an important role in the generating and progress of pancreatic carcinoma.
出处 《胃肠病学和肝病学杂志》 CAS 2003年第6期535-537,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 CYCLIND1 P27^KIPL 胰腺癌 临床意义 淋巴结转移 肿瘤分化 Pancreatic carcinoma CyclinD 1 p27 kipl
  • 相关文献

参考文献1

二级参考文献10

  • 1[1]Cai JL. Moderm Therapy for scar [M]. Beijing. Renmin Weisheng Chubanshe (People's Medical Publishing House), 1998;28-31.
  • 2[2]Favrot M, Coll JL, Louis N, Negoescu A. Cell death and cancer: Replacement of apoptotic genes and inactivation of death suppressor genes in therapy [J]. Gene Ther, 1998;5:728-739.
  • 3[3]Bao WH. Practical scarology [M]. Beijing. Beijing Yike Daxue Chubanshe (Publishing House of Beijing Medical University), 2000;86-91.
  • 4[4]Cordeiro MF, Gay JA, Khaw PT. Human anti-transforming growth factor-beta2 antibody: A new glaucoma anti-scarring agent [J]. Invest Ophthalmol, 1999;40(10):2225-2234.
  • 5[5]Choi BM, Kwak HJ, Jun CD, Park SD, Kim KY, Kim HR Chung HT. Control of scarring in adult wounds using antisense transforming growth factor-beta 1 oligodeoxynucleotides [J]. Immunol Cell Biol, 1996;74(2):144-149.
  • 6[6]Jia CY, Chen B, Wang DW. The effect of PCMV4-hTGFβ1 on wound healing and scar forming on rats [J]. Zhonghua Zhengxing Shaoshang Zazhi, 1999;15(3):170-173.
  • 7[7]Iocono JA, Ehrlich HP, Keefer KA, Krummel TM. Hyaluronan induces scarless repair in mouse limb organ culture [J]. J Pediatr Surg, 1998;33(4):564-567.
  • 8[8]Tredget EE, Shahkowsky HA, Pannu R, Nedelec B, Twashina T, Ghahary A, Taerum TV, Scott PG. Transforming growth factor-β in thermally injured patients with hypertrophic scars: Effect of interfron α-2b [J]. Plast And Reconstr Surg, 1999;102(5):1317-1328.
  • 9[9]Luo CQ. Advances in Gene Diagnosis and Therapy [M]. Zhengzhou. He'nan Yike Daxue Chubanshe (Publishing House of He'nan Medical University), 1999;193-197.
  • 10[10]Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM. p27kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest [J]. Genes Dev, 1994;78:59-65.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部